We have segregated DRI+ individuals into two categories according to whether or not their class II+ cells stimulated T lymphocyte clones specific for or restricted to DR1. In a majority of cases (87%), failure to stimulate was a property of cells having the B14;DR1 haplotype and/or nonclassical 21-hydroxylase deficiency. Absence of clonal proliferation could not be explained by release of an intercellular suppressor factor or by stimulator cell absorption of interleukin 2. Homozygous cells inheriting both stimulatory (DR1,) and nonstimulatory (DR1J haplotypes did not successfully mediate clonal expansion, implying that a trans acting factor operates intracellularly to modify both DRI alleles or their products. Other DR alleles did not appear to be affected as evidenced by normal proliferative responses of T lymphocyte clones restricted to DR2 or DR7 and stimulated by DR1X,2 and DRlX,7 cells, respectively. By two-dimensional gel analysis, we have further identified a 50-kD surface glycoprotein contained in anti-DR immunoprecipitates of DR1X, but not DR1. or non-DR1 cellular lysates. This 50-kD structure had antigenic and peptide identity to DRa and fi chains but was resistant to dissociation under conditions that normally separate DRa and ,8 (8 M urea plus 5% 2-mercaptoethanol); boiling in sodium dodecyl sulfate was required to segregate the component polypeptides of the 50-kD heterodimer. We postulate that a product of a novel combinatorial association between constitutive chains of DR may interfere with or compete for normal T cell receptor recognition of DR1 as both an alloantigen and a restricting element. We further propose that gene abnormalities within the class III region of a haplotype associated with nonclassical 21-hydroxylase deficiency may extend into the DR subregion of the major histocompatibility complex with consequent aberrations in DR1 presentation.
Introduction and the sequence of interactions between T cell receptor, antigen, and the two constituent chains of class II structures continue to be a provocative issue.
Severe deficiency of 2 1-hydroxylase (21-OH) causes a recessive inborn error of metabolism known as congenital adrenal hyperplasia. A lack of sufficient 21-OH enzyme activity interrupts normal adrenal steroidogenesis such that the immediate precursor in the pathway, 17-hydroxyprogesterone, is shunted into excessive production of androgens with subsequent symptoms of virilization. Multiple variants of the disease have been described (reviewed in reference 6), which range in severity from the classical "salt wasting" and "simple virilizing" forms present at birth to the nonclassical "cryptic" and "late onset" variants where clinical symptoms fail to become evident or are not apparent until puberty. Different forms of the disease are frequently inherited in genetic linkage disequilibrium with different extended HLA haplotypes (7, 8) . In the case of nonclassical deficiency, this haplotype includes HLA-DRl and B14 (8) . Two genes for 21-OH, one active and one nonfunctional, have been mapped alternating with the complement C4A and C4B genes within the class III region of the human MHC (9, 10). Although there is extensive evidence documenting a deletion ofthe active 21-OHB gene in some cases of classical 21-OH deficiency (1 1), other reports have referred to a duplication of both the C4B gene (12) and one (11) in some cases of nonclassical deficiency. It remains unclear to what extent DNA rearrangements have functionally altered particular genes associated with the disease and whether those modifications are confined to the class III region of the affected haplotypes.
Despite the location of 21-OH genes within the human MHC adjacent and telomeric to DR subregion genes, no consistent associations with immunological abnormalities, in particular antigen presentation by class II structures, have been described in 2 1-OH-deficient patients or related obligate car- riers. In this report, we demonstrate failure of certain DR1+ cells to mediate activation and proliferation of some DR 1-restricted or specific T lymphocyte clones. This does not appear to reflect a "split" of the DRl alloantigen and seems to be inherited in a dominant fashion, usually in linkage disequilibrium with HLA-B14 and nonclassical 21-OH deficiency. Only some epitopes ofthe DRl antigenic complex are involved with the defective trait, and successful presentation of other DR allelic products is not obstructed. We further show that deviant antigen presentation is positively correlated with the presence of a novel 50-kD surface structure having DR peptide and antigenic homology.
Methods
Human Tlymphocyte clones (TLC). Methods for the derivation, cloning, and screening of T cells used in this study have been detailed elsewhere (13) . Clone GM-ICl was cloned from a bulk population of responder GMc cells (Al 1,24; Bw58,w60; Cw3,w5; DR1,7; DQwl,w2; DRw53; DPw2,w4) that had been sequentially stimulated with trinitrophenyl (TNP)-modified peripheral blood mononuclear cells (PBMC) of the same donor. Clone RD-2A4 originated from a primary mixed lymphocyte response between PBMC of responder RD (Al,w30; B8,49; DR3,w6; DQwl,w2; DPw2,w4) and irradiated stimulator PBMC from GMc. Clonal expansion was carried out with antigenic stimulation every 7 d in Linbro 24-well plates (Flow Laboratories, Inc., McLean, VA) by using 0.5 X 106 cloned responder cells mixed with 1.0 X 106 irradiated (3,000 rad from a 'Co source) PBMC in a total volume of 1.0 ml RPMI 1640 medium supplemented with 2 mM L-glutamine, 50 ,ug/ml gentamicin sulfate (Gibco, Grand Island, NY), 24 mM sodium bicarbonate (Mallinckrodt, Inc., St. Louis, MO), 25 mM HEPES (Sigma Chemical Co., St. Louis, MO), 10% human serum from defibrinated plasma, and 5-10% interleukin 2 (IL-2)-containing medium. Where the responding clone was specific for TNP, stimulator cells were conjugated with trinitrobenzene sulfonic acid (ICN Nutritional Biochemicals, Cleveland, OH) by methods previously described (14) . Cells were passed over Isolymph (Teva, Ltd., Jerusalem, Israel) density gradients to remove cellular debris and residual stimulator cells before cryopreservation in 90% fetal calf serum (FCS; Gibco) with 10% dimethylsulfoxide (DMSO). After 5 mo of in vitro expansion, both clones were > 98% positive by flow cytometric analysis for CD3, CD4, CD2, and DR surface antigens and < 3% positive for the CD8 marker.
IL-2. IL-2-containing medium was prepared from spleens of trauma patients, as previously described (13) , or from buffy coats (Gulf Coast Regional Blood Center, Houston, TX) according to existing protocols (15, 16 (19) .
HLA typing. Donor leukocytes were typed for HLA-A, B, C, DR, DQ histocompatibility antigens using standard serologic techniques (20, 21 Two-dimensional (2-D) polyacrylamide gel electrophoresis (PAGE). Immunoprecipitated molecules were analyzed by 2-D PAGE according to published protocols (25) using a 3.5-9 pH gradient isoelectric-focusing (IEF) gel in the first dimension and a 10% polyacrylamide slab gel in the second dimension. Gels were fixed, unless otherwise stated, dried, and autoradiographed at -70'C using Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY) with intensifying screens.
2-D Western blotting. 2-D slab gels containing unlabeled, immunoprecipitated cellular proteins were electroblotted to nitrocellulose paper (Schleicher & Schuell Inc., Keene, NH) by methods previously described (31) . Nonspecific binding sites were blocked by incubation in 0.05 M Tris-buffered saline with 5% nonfat dry milk, followed by an overnight exposure to mAb culture medium, and exposed an additional 6 h to '25I-sheep anti-mouse Ig (Amersham Corp.). Washed and dried blots were autoradiographed as above.
Cleveland peptide mapping. Peptide mapping was performed essentially as has been described (32). 2-D gels were dried and autoradiographed without prior fixation, and the molecules of interest were excised and eluted overnight at 37°C into 0.125 M Tris buffer, pH 6.8, containing 0.1% sodium dodecyl sulfate (SDS) and 20% glycerol. Aliquots ofeluted material, boiled or not boiled, were loaded into lanes of a 15% acrylamide gel having a 7-cm 4% acrylamide-stacking gel and were overlayered with 50 ;d of diluted enzyme in 0.125 M Tris buffer, pH 6.8, with 10% glycerol, 0.1% SDS, and bromophenol blue. Digestive enzymes included Staphylococcus aureus V8 protease (1 or 10 Mug/well; Miles Laboratories, Inc., Naperville, IL), chymotrypsin (2 Ag/ well; Miles Laboratories, Inc.), and papain (0.9 pg/well; Sigma Chemical Co.).
Results
Failure of some DR]' cells to stimulate DR1-restricted and -specific TLC. Previous screening and mAb-blocking studies performed in this laboratory have established that clone GM-lCl was specific for TNP in the context of DRl (27) , whereas clone RD-2A4 was alloreactive and specific for DR1. However, extensive panel analysis of both clones revealed that stimulator cells from a significant number of DR1+ individuals were not able to mediate clonal expansion as measured in a standard proliferation assay. Representative data illustrating this finding are shown in Table I where PBMC from donors GLG, ReG, and OrB were not able to promote [3H]TdR incorporation by either clone despite the serologically defined presence of DRI on the surface of these cells. In all instances, equivalent clonal proliferation results were observed whether DR1+ allogeneic stimulators were prepared from PBMC or EBV-transformed lines. Ability or inability to stimulate was always a property equally applicable to both the alloreactive and TNP-specific clones; no antigen-presenting cell ever stimulated one clone but not the other.
We have used the following nomenclature to define this functional dichotomy between some DRI+ stimulators. Cells that were proficient stimulators of either clonal response carried the phenotypic designation DRln, whereas cells that were ineffective stimulators were designated DRl,. (Table V) . Consequently, although at least one determinant ofthe DRl complex has been deleted or altered, other determinants are unaffected and are capable of being recognized by their corresponding T cell receptors on other clones. Co-precipitation of a 50-kD glycoprotein with DR from some DRI' cells. We attempted to compare the molecular profile of DRl1,, and DRlI antigens using standard techniques designed to separate these molecules by charge and molecular weight. When radioiodinated cellular lysates were subjected to immunoprecipitation with anti-DR mAbs followed by IEF in the first dimension and SDS-PAGE in the second dimension, we identified a unique species having a molecular weight of 50 kD and an isoelectric point (pl) between 5 and 6 that co-precipitated with a and (3 chains of DR from B14';DRI+ cis cells (Fig. 1 B) , but not from B14-;DRI' cells ( Fig. 1 A) (Fig. 3) . Co-precipitation of the 50-kD protein was noticeably absent from immunoprecip- (F) was utilized in negative control immunoprecipitations. Orientation of a and polypeptide chains is as given in Fig. 1 . We believe that molecules appearing just below the bracketed 50-kD region represent co-precipitating class I heavy chains. Fig. 4 E) and anti-DP (B7/2 1; data not shown) mAbs. We interpret this to mean that the 50-kD molecule shares crossreactive determinants only with DR a and/or (3 chains or that the 50-kD species noncovalently complexes with DR molecules but not with DQ or DP molecules. In further experiments (not shown), we have found that the 50-kD complex is not a class I antigen because it is not precipitated with mAb against HLA-A, B, C or (-2 microglobulin, nor does it represent a chondroitin sulfate modified invariant chain.
The 50-kD species includes DR antigenic determinants. To pursue this evidence for common antigenic determinants between the 50-kD protein and DR a and/or (3 chains, we ran unlabeled anti-DR immunoprecipitations on 2-D gels, transferred them to nitrocellulose paper, and immunoblotted with a panel ofclass II mAbs. All anti-DR mAbs tested had specificity for the 50-kD molecule (L243, Fig. 4 B) , whereas anti-DQ mAbs did not blot (data not shown).
Dissociation ofthe 50-kD species by boiling. After excising spots representative of DR a and (3 and the 50-kD species from 2-D gels followed by elution and rerunning on one-dimensional SDS-PAGE gels under nonreducing conditions, we observed that the 50-kD band dissociated into two constituent chains if the eluted material was boiled before rerunning. If treatment did not include boiling, no separation was apparent (Fig. 5, compare lanes 3 and 6) . The component chains of the 50-kD complex appeared to have molecular weights equivalent to DR a and (3 chains (Fig. 5, compare lanes 6 and 7) . (Fig. 6 A, compare lanes 3 and 6) . However, boiling followed by enzymatic digestion produced a peptide map virtually identical to that of purified DR a and (3 chains mixed together (Fig. 6 B, compare lanes 6 and 7) . These data suggest that the 50-kD species is composed of DR a and (3 the DRlI complex could account for the appearance of the 50-kD heterodimer and consequently the eradication of one or more antigenic determinants. Alternatively, a mutation in one or more DR subregion genes could generate the same result. In either instance, increased avidity of interaction between the two chains could interfere with antigen-presenting properties or with potential binding interactions of the class II complex and a specific T cell receptor complex. In summary, we have evidence for a novel combinatorial association between constituent chains of the DRl complex, the product of which may functionally interfere with or compete for normal T cell receptor recognition of DRl as both an alloantigen and as a restricting element. It is especially noteworthy that a defect of this nature is highly correlated with the B14;DRI-extended haplotype commonly inherited with nonclassical 21-OH deficiency, a haplotype known to contain at least one major rearrangement of DNA downstream ofthe DR subregion. Others have speculated that an extended haplotype of this nature may be retained if duplications of the C4B and 21-OHB genes carried with B14 and DRl introduce sufficient misalignments ofthe chromosomes to suppress recombination in that region and across portions of the adjoining MHC (35) . Although deficiencies of immunological function in such patients have not previously been reported, our data suggest that additional HLA gene product structural abnormalities are inherited with this haplotype, that modifications of the DNA extend beyond the class III region, and that at least one consequence may be abnormal surface presentation of the DRI antigen.
